Lionsgate’s Upcoming Movies: The Full Slate of Releases Explained

As the entertainment landscape evolves with streaming dominance and blockbuster fatigue, Lionsgate stands firm as a powerhouse studio blending franchise extensions, genre thrills, and bold originals. Fresh off hits like John Wick: Chapter 4 and the enduring Saw legacy, Lionsgate has unveiled an ambitious slate for 2025 and beyond. This comprehensive breakdown dives into every confirmed and highly anticipated release, analysing production details, star power, directorial visions, and box office potential. From heart-pounding action to spine-chilling horror, Lionsgate promises to deliver the adrenaline rush fans crave.

The studio’s strategy shines through in its diversified portfolio: leveraging proven IPs while nurturing fresh talent. With a keen eye on theatrical returns amid hybrid releases, Lionsgate targets mid-budget spectacles that punch above their weight. Expect a mix of R-rated grit, family-friendly adaptations, and prestige dramas, all timed to capitalise on seasonal windows. As we dissect the full list, patterns emerge—horror resurgence, action universe expansions, and biopic gambles—that could redefine Lionsgate’s trajectory.

Lionsgate’s Release Calendar: Key Dates and Anchors

Lionsgate’s 2025 lineup kicks off strong, with films spaced strategically to avoid overlap and maximise buzz. Here’s the roadmap:

  • Early 2025: Kickstarts with genre favourites to build momentum.
  • Mid-Year Peaks: Summer blockbusters and franchise entries dominate.
  • Late 2025 and 2026: Awards contenders and sequels round out the year, spilling into the next.

This scheduling reflects savvy market awareness, countering superhero saturation with visceral, character-driven stories. Production timelines, delayed by strikes but now accelerating, ensure high polish across the board.

Ballerina (June 6, 2025)

Leading the charge is Ballerina, the first spin-off from the John Wick universe sans Keanu Reeves as the Baba Yaga. Directed by Len Wiseman (Underworld), it stars Ana de Armas as Eve Macarro, a vengeful assassin trained in the Ruska Roma tradition. Reeves cameos, alongside Ian McShane, Lance Reddick (in his final role), Norman Reedus, Anjelica Huston, and Gabriel Byrne.

The film’s appeal lies in expanding Wick’s mythology without over-reliance on the lead. De Armas, fresh from No Time to Die, brings lethal grace, while practical stunts and gun-fu choreography promise spectacle. Lionsgate positions it as a female-led action milestone, with a reported $50 million budget eyeing $200 million globally. Analysts predict it could outgross Atomic Blonde if word-of-mouth ignites.

Saw XI (September 26, 2025)

Horror fans rejoice: Saw XI revives Jigsaw’s traps under Kevin Greutert’s direction. Tobin Bell returns as John Kramer, with Shawnee Smith reprising Amanda. Plot details remain shrouded, but teases suggest a post-Saw X timeline exploring legacy traps amid a new game.

The franchise’s resilience astounds—Saw X grossed $107 million on a $12 million budget. Expect gore innovations, moral dilemmas, and twists that honour the series’ puzzle-box ethos. Lionsgate banks on Halloween proximity for a $50-80 million haul, solidifying horror as its profit engine.

Franchise Expansions: Building Universes

Lionsgate excels at IP stewardship, turning one-offs into empires. Beyond Ballerina and Saw, expect ripples from Borderlands (despite its 2024 stumble) and potential Hunger Games extensions.

Borderlands Sequel Tease and Recovery

After Borderlands‘ modest $36 million domestic against $115 million costs, Lionsgate pivots wisely. Eli Roth’s adaptation boasted Cate Blanchett, Kevin Hart, and Jamie Lee Curtis, but script woes tanked it. A sequel remains in “development hell,” but whispers of a 2026 reboot with Gearbox oversight hint at redemption. Lionsgate’s faith persists, eyeing video game adaptations’ billion-dollar precedent like The Last of Us.

Now You See Me 3 (November 14, 2025)

The magic-heist trilogy concludes with Jesse Eisenberg, Woody Harrelson, and newcomer Justice Smith leading the Four Horsemen. Directed by Ruben Fleischer (Venom), it promises globe-trotting illusions and FBI showdowns. Lionsgate revives the franchise post-Now You See Me 2‘s $365 million haul, blending spectacle with social commentary on financial wizards. Mid-budget at $60 million, it targets family audiences for holiday dominance.

Horror Dominance: Lionsgate’s Bloody Bread and Butter

No studio rivals Lionsgate’s horror output. Post-The Strangers: Chapter 1 (2024’s sleeper hit) and Dear David, the pipeline overflows.

The Strangers: Chapter 2 (2026)

Renny Harlin directs the trilogy’s middle act, escalating masked intruders’ terror. Madelaine Petsch returns, with Froy Gutierrez. Budgeted modestly, it capitalises on Chapter 1’s $50 million global, aiming for slasher revival amid Scream fatigue.

The Killer’s Game (2025)

Lionsgate’s dark comedy-thriller stars Dave Bautista as a hitman marked for death by mistake. Directed by J.J. Perry, with Sofia Boutella and Terry Crews. Adapted from Igor Savella’s novel, it mixes hits with heart, echoing John Wick vibes on a $20 million scale.

Other horrors like Subservience sequels and Vampire Academy reboots lurk, underscoring Lionsgate’s genre mastery.

Prestige Plays: Biopics and Dramas

Diversifying beyond schlock, Lionsgate courts Oscars.

Michael (April 18, 2025)

Antoine Fuqua’s Michael Jackson biopic stars Jaafar Jackson as the King of Pop, with Colman Domingo, Nia Long, and Jeffrey Wright. Spanning 1960s-1990s, it tackles triumphs and controversies head-on. $100 million budget positions it as a musical event, rivaling Bohemian Rhapsody‘s $910 million. Lionsgate anticipates controversy boosting buzz.

White Bird (2024, Expanding Reach)

Marc Forster’s Holocaust drama, starring Helen Mirren and Gillian Anderson, shifts to VOD post-theatricals. Tied to Wonder, it emphasises empathy amid genre fare.

Originals and Wild Cards

Innovation thrives: Ronin (2025), a heist thriller with new faces; Deep Cover, Bryce Dallas Howard’s undercover cop saga; and 70 Braids, a fashion-world drama eyeing festivals.

Lionsgate scouts IP like video games (Mad Max echoes in Borderlands) and YA novels, blending with streamer deals for dual revenue.

Industry Impact and Box Office Projections

Lionsgate’s slate could gross $1.5 billion by 2026, per Box Office Mojo forecasts. Strengths: Cost efficiency (averaging $40-60 million budgets), star draw, and genre loyalty. Challenges: Superhero shadows, streaming piracy. CEO Jon Feltheimer champions theatrical exclusivity for tentpoles, echoing successes like Anyone But You.

Trends signal horror’s gold rush—Saw X proved R-rated viability—and action’s female empowerment shift. Compared to Universal’s sprawl, Lionsgate’s focus yields higher ROI. Predictions: Ballerina sparks Wick Phase 2; Michael ignites culture wars.

Production hurdles, from 2023 strikes to VFX crunches, tested resilience, but Lionsgate’s indie roots prevail. Partnerships with Thunder Road (John Wick) and Blumhouse-adjacent horrors fortify.

Conclusion

Lionsgate’s future movies form a thrilling mosaic: franchise fireworks, horror hauls, and prestige pivots. Whether you’re queuing for Ballerina‘s bullets or Saw XI‘s saws, this slate reaffirms the studio’s knack for crowd-pleasing potency. As 2025 unfolds, Lionsgate doesn’t just release films—it reignites cinema’s pulse. Which entry has you booking tickets first? The box office battle awaits.

References

  • Deadline Hollywood, “Lionsgate Sets 2025 Release Dates,” 15 October 2024.
  • Variety, “Ana de Armas Talks Ballerina Stunts,” 22 August 2024.
  • Box Office Pro, “Horror Franchise Analysis: Saw’s Enduring Appeal,” 5 September 2024.